| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6005601 | Brain Stimulation | 2014 | 36 Pages |
Abstract
Our data demonstrate the feasibility of tVNS over a period of 6 months. There was no clinically relevant improvement of tinnitus complaints. Our data suggest tVNS to be considered safe in patients without a history of cardiac disease.
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Peter M. Kreuzer, Michael Landgrebe, Markus Resch, Oliver Husser, Martin Schecklmann, Florian Geisreiter, Timm B. Poeppl, Sarah J. Prasser, Goeran Hajak, Rainer Rupprecht, Berthold Langguth,